References
- Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, . The DRESS syndrome: a literature review. Am J Med 2011;124:588–97.
- Hicks C, Gulick RM. Raltegravir: the first HIV type 1 integrase inhibitor. Clin Infect Dis 2009;48:931–9.
- Kearney BP, Sayre JR, Flaherty JF, Chen SS, Kaul S, Cheng AK. Drug–drug and drug–food interactions between tenofovir disoproxil fumarate and didanosine. J Clin Pharmacol 2005;45:1360–7.
- Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, . Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007;156:609–11.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30: 239–45.
- Bonta PI, Vermeulen JN, Speelman P, Prins JM. Severe abacavir hypersensitivity reaction in a patient tested HLA-B*5701 negative. AIDS 2008;22:1522–3.
- Fox J, Newton P, Daly R, Blume A, Marett B, Greene L, . An unusual abacavir reaction. AIDS 2008;22:1520–2.
- Claudio GA, Martin AF, de Dios Perrino S, Velasco AA. DRESS syndrome associated with nevirapine therapy. Arch Intern Med 2001;161:2501–2.
- Zhang K, Modi G, Hsu S. Letter: DRESS syndrome associated with raltegravir. Dermatol Online 2011;17:14.